Skip to main content
. 2014 Oct 27;9(10):e111431. doi: 10.1371/journal.pone.0111431

Figure 5. Further Wnt/β-catenin signaling inhibition sensitizes hypoxic OS cells to doxorubicin.

Figure 5

MG-63 OS cells were treated with increasing concentrations of doxorubicin under hypoxic conditions in the presence of the tankyrase inhibitor XAV939, the porcupine inhibitor IWP-2, or DMSO alone. Half maximal inhibitory concentrations (IC50) were calculated, and the percent IC50 relative to DMSO alone was determined. Asterisks indicate statistical significance (*p<0.05).